Physician
Pediatric Hematology & Oncology
Dr. Cynthia S. Kretschmar, MD
|
|
Give Review
Cynthia Kretschmar is an expert in the field of Pediatric Hematology & Oncology. She graduated from Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine She received 1 awards: "Super Doctor". Dr. Cynthia S. Kretschmar has written publications. She has 36 publications published with PubMed. The lastest publication is: 'Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.'
Publications
- A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
- Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational ...
- Pediatric germ cell tumors.
- Neuroblastoma in adults. Three case reports and a review of the literature.
- A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group study.
- Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
- myc gene amplification and expression in primary human neuroblastoma.
- Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase...
- Improved survival in neuroblastoma using multimodality therapy.
- Central nervous system neurocytoma and neuroblastoma in adults--report of eight cases.
- Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study.
- Influence of local-regional lymph node metastases on prognosis in neuroblastoma.
- Chemotherapy for patients with recurrent or refractory neuroblastoma: a POG Phase II study.
- Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
- Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience.
- Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive...
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
- Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
- Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
- Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
- Desmoplastic small cell tumor: a report of three cases and a review of the literature.
- Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Proto...
- Urological aspects of intra-abdominal desmoplastic small round cell tumor of childhood: a preliminary report.
- The desmoplastic round cell tumor: a new solid tumor of childhood.
- Ewing's sarcoma and the "peanut" tumors.
- Improved prognosis for infants with stage IV neuroblastoma.
- Stage IV-N: a favorable subset of children with metastatic neuroblastoma.
- Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.
- Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.
- Ototoxicity of preradiation cisplatin for children with central nervous system tumors.
- Stage IV neuroblastoma in infants. Long-term survival.
- Chemotherapeutic treatment of extensive optic pathway tumors in infants.
- Germ cell tumors of the brain in children: a review of current literature and new advances in therapy.
- Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.
Schools
Yale University
Yale New Haven Hospital
Dana Farber
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Kapil Saxena, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Sartain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lars Mueller, MD |
|
|
Dr. Alex Kentsis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara A. Degar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew L. Kung, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amy E. Sobota, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily K. Carr, MD
This Doctor is OpenDoctor Recommended.
|